[
  {
    "ts": null,
    "headline": "RadNet price target raised to $94 from $80 at Truist",
    "summary": "Truist raised the firm’s price target on RadNet (RDNT) to $94 from $80 and keeps a Buy rating on the shares. The firm, which is updating its estimates to reflect Q3 earnings, raised FY24 guidance and the recently announced AI collaboration with GE Healthcare (GEHC), notes that it is raising its FY24, FY25 and FY26 adjusted EBITDA estimates for RadNet to $280.4M, $308.0M and $336.0M, respectively. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news",
    "url": "https://finnhub.io/api/news?id=4bf31df019616eb3edbc3aa967afd4e67b7e7b1049d196c62ae6a21929e7a59a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732969237,
      "headline": "RadNet price target raised to $94 from $80 at Truist",
      "id": 131722606,
      "image": "",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "Truist raised the firm’s price target on RadNet (RDNT) to $94 from $80 and keeps a Buy rating on the shares. The firm, which is updating its estimates to reflect Q3 earnings, raised FY24 guidance and the recently announced AI collaboration with GE Healthcare (GEHC), notes that it is raising its FY24, FY25 and FY26 adjusted EBITDA estimates for RadNet to $280.4M, $308.0M and $336.0M, respectively. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news",
      "url": "https://finnhub.io/api/news?id=4bf31df019616eb3edbc3aa967afd4e67b7e7b1049d196c62ae6a21929e7a59a"
    }
  },
  {
    "ts": null,
    "headline": "RadNet’s DeepHealth expands FDA clearance for SmartMammo solutionGE",
    "summary": "DeepHealth, a wholly-owned subsidiary of RadNet (RDNT), has received expanded FDA 510(k) clearance for its innovative mammography software. SmartMammo Dx, the AI algorithm within SmartMammo, is now FDA-cleared to be compatible with GE HealthCare’s (GEHC) Senographe Pristina mammography systems. SmartMammo Dx was first cleared in May 2012 in conjunction with HOLOGIC mammography systems, where its performance has also been tested and cleared in patients with unilateral breasts and with breast impl",
    "url": "https://finnhub.io/api/news?id=392c269179e9ec7a6e77ba2660e2fc9f4b6d9cad1940faefdfd9c8fcc57cb7e0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732964712,
      "headline": "RadNet’s DeepHealth expands FDA clearance for SmartMammo solutionGE",
      "id": 131721542,
      "image": "https://media.zenfs.com/en/tipranks_452/bd23518bddbecaa2e26b66cd7da7f21e",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "DeepHealth, a wholly-owned subsidiary of RadNet (RDNT), has received expanded FDA 510(k) clearance for its innovative mammography software. SmartMammo Dx, the AI algorithm within SmartMammo, is now FDA-cleared to be compatible with GE HealthCare’s (GEHC) Senographe Pristina mammography systems. SmartMammo Dx was first cleared in May 2012 in conjunction with HOLOGIC mammography systems, where its performance has also been tested and cleared in patients with unilateral breasts and with breast impl",
      "url": "https://finnhub.io/api/news?id=392c269179e9ec7a6e77ba2660e2fc9f4b6d9cad1940faefdfd9c8fcc57cb7e0"
    }
  }
]